Introduction
============

Given the widespread prevalence of obesity and associated diseases, efforts are underway to reduce the body weight gain through modulating the energy intake and/or expenditure. A large portion of the resting energy expenditure is spent on thermoregulation ([@B85]). Uncoupled respiration -- a process where the oxidative phosphorylation is uncoupled from ATP generation, shivering thermogenesis, and diet-induced thermogenesis play an important part in thermal homeostasis. Overall, thermogenesis accounts for about 15% of the daily energy expenditure ([@B163]) or about 20% of the oxygen consumed ([@B133]). Thus, activation of uncoupled respiration could be a useful strategy to counter body weight gain. In mammals, brown adipose tissue (BAT) plays an important role in uncoupled respiration. While some previous studies had shown the existence of BAT in adult humans ([@B60]; [@B64]; [@B19]), it was the (re)demonstration of active BAT in adult humans about 10 years ago ([@B115]; [@B30]; [@B167]; [@B188]) that has greatly increased the research efforts to understand and modulate this tissue. In humans, BAT is often seen in the cervical, upper supraclavicular area, mediastinal and perirenal regions. Due to its intense PET signal in the upper supraclavicular area (abbreviated "USA"), it became popularly known as "USA" fat ([@B26]).

Brown adipose tissue plays an active role in thermoregulation in adult humans ([@B24]). Biochemical and ultrastructural analyses identified that this tissue is rich in mitochondria and possesses a unique protein called the uncoupling protein 1 (UCP1). Other pathways, such as the glycerol-3-phosphate shuttle ([@B4]) and creatinine cycling ([@B71]) may also contribute to heat generation along with UCP1 mediated uncoupling. These molecules provide the tissue with a thermogenic capacity which helps in maintaining body temperature without the need to shiver constantly. The heat thus generated is termed as non-shivering thermogenesis (NST). Some recent review articles have looked into the effect of various biochemical mediators on UCP1 activity and molecular tools used to study UCP1 functioning ([@B79]; [@B130]). Given the potential of regulated uncoupling to dissipate energy, novel chemical uncouplers are being investigated ([@B122]) in other tissues such as WAT and skeletal muscle.

A lot of our understanding of BAT functioning comes from rodent studies. In mice, the interscapular BAT (IBAT) is the primary BAT depot, while brown adipocytes are also present in the supraclavicular region (scBAT). Several mice depots with topological similarities to human BAT-like and beige depots were identified recently ([@B186]). Another study has shown that the gene expression pattern of mice scBAT was similar to that of human scBAT ([@B110]).

Under prolonged cold conditions, the brown fat size and activity increases, a term called BAT "recruitment." BAT recruitment is associated with increased proliferation and differentiation of BAT precursor cells. Exposure to cold also increases BAT volume and activity in humans ([@B16]) and also in individuals with obesity and type 2 diabetes ([@B58]). Increased sympathetic nervous system (SNS) activity, including on cold exposure, is a primary mechanism of BAT activation. Activated SNS releases norepinephrine which acts on the beta-adrenergic receptors on the BAT. In addition to epinephrine and norepinephrine, dopamine stimulation of brown adipocytes was also associated with increased oxygen consumption, UCP1 protein and mitochondrial mass ([@B82]). Prolonged exposure of mice to cold not only leads to brown fat recruitment but also to appearance of white adipocytes containing multilocular fat droplets and UCP1-expressing mitochondria -- a process called "browning" of the white adipose tissue (WAT) depots. Brown-like adipocytes in WAT can arise from several origins -- through the development of distinct subpopulations or through the trans-differentiation of differentiated white adipocytes ([@B120]). Additionally, the "brite" cells may also develop through the bi-directional interconversion of some cells between brite and white adipocyte phenotypes ([@B134]). In spite of many molecular similarities between the BAT and brite cells, there is a differential expression of certain genes between BAT and brite cell. These include metabolic proteins (e.g., Slc27a1), inflammatory proteins (e.g., CD40 and CD137) and transcription factors (Tbx15 and Zic1) ([@B169]; [@B176]). The gene expression profile of BAT in human infants resembles that of the classical BAT ([@B93]), though they also express typical brite marker proteins TBX1 and CD137 ([@B139]). The BAT in the neck of adult humans contains a mixture of classical brown and brite cells ([@B68]; [@B93]). While the expression of browning genes in mice is greater in subcutaneous WAT (scWAT) compared to visceral WAT (vWAT), an opposite pattern of browning gene expression with vWAT having higher expression than scWAT was observed in humans ([@B191]).

Brown adipose tissue and UCP1 levels have been shown to be involved in body weight regulation, glucose, and lipid homeostasis in mice ([@B83]; [@B43]; [@B151]). Mice strains which have a tendency to be obese have comparable BAT levels and activity but diminished browning of WAT depots ([@B55]; [@B179]). Interestingly, transplantation of BAT from healthy mice into the visceral cavity of apoE--/-- mice led to a 20% reduction in atherosclerotic lesions ([@B74]). Similarly, transplantation of human beige tissue in mice significantly improved their metabolic parameters ([@B109]). Obese humans have reduced BAT compared to those with normal weight ([@B121]) and the amount of detectable BAT correlated inversely with total, subcutaneous and visceral adiposity ([@B136]). Individuals who are BAT-positive have a reduced probability of type 2 diabetes and obesity ([@B30]). Another study employing retrospective analysis of FDG-PET/CT scans of 4852 patients showed that BAT-positive patients had lower visceral, subcutaneous and liver fat content ([@B20]). BAT-positive individuals have better insulin-stimulated glucose disposal compared to BAT-negative individuals ([@B25]). Among patients with cardiovascular comorbidities, those with higher BAT fraction had better metabolic profiles ([@B48]). The activated BAT was shown to be associated with reduced arterial inflammation and fatty liver ([@B114]). Even in newborns, those with the higher BAT at birth were shown to have lesser fat-gain over the period of 6 months ([@B41]). Activation of BAT by cold-exposure was shown to be associated with improved glucose uptake, insulin sensitivity and reduced plasma FFA levels ([@B66]), and lesser central adiposity ([@B54]). Activated BAT is also associated with other physiological benefits such as amelioration of obesity-associated reduction in male fertility ([@B94]) and improved menstrual regularity in rat model of Polycystic ovary syndrome (PCOS) ([@B185]). Thus, BAT recruitment has been suggested as an anti-obesity agent in humans ([@B183]). Individuals with active BAT weighed on an average 4 kg less than BAT negative individuals ([@B86]). Leaner individuals had about 50% higher UCP1 mRNA levels. Interestingly, the UCP1 levels accounted for about 50% of BMI variance ([@B87]).

Given the strong correlation between active BAT and positive metabolic and physiological responses, there is an intense interest in understanding the biology and regulation of this tissue. The level of interest can be gleaned from the fact that the search for the term "brown adipose tissue" in Pubmed produced a list of over 10000 articles, most of which were published in the past decade. While there are many reviews that cover specific aspects of brown and brite adipocyte biology and some of the recent ones are referenced in this review, our aim is to provide an integrative overview of the recent literature and current understanding of brown/brite adipocyte biology and functioning.

Substrates Utilized by Brown Fat for Heat Production
====================================================

Brown fat is a metabolically active tissue that can metabolize a variety of substrates for the production of heat. A major source for short-term activity is the intracellular lipid that is stored in the form of multi-locular droplets. However, knockout of essential enzymes of lipolysis ([@B138]; [@B142]) indicate that lipolysis is not essential for cold-induced thermogenesis in mice. However, inhibition of intracellular lipolysis by feeding nicotinic acid was associated with a diminished increase in cold-induced BAT activity in men ([@B14]).

Brown fat can also metabolize a variety of extracellular substrates, primary among which is glucose. The rapid uptake of glucose by this tissue is the reason for its prominent display during the FDG-PET imaging. It has been suggested that the glucose can be used for *de novo* fatty acid synthesis which is then channeled to a pool of triacylglycerol (TAG) which is rapidly hydrolyzed to yield fatty acids that can serve as substrates for increased thermogenesis ([@B65]). Circulating lipids and lipoproteins are also utilized by BAT ([@B8]; [@B12]; [@B73]; [@B15]). The clearance of glucose and triglycerides by cold-activated BAT can account for about two-thirds of total increase in substrate clearance ([@B8]). Circulating acylcarnitines ([@B144]), as well as lipoproteins ([@B61]) can also be utilized by activated BAT as substrates. Lipid oxidation was shown to be important for BAT thermogenic function ([@B53]). A correlation between BAT activity and serum HDL cholesterol levels has been reported ([@B9]). Thus, the BAT, when activated, could be an important organ for clearance of glucose and lipid species.

Circulating Modulators of Brown Adipose Activity and Browning
=============================================================

Several previous and recent studies have shown that BAT activation and WAT browning are regulated by the actions of various hormones. The regulation of BAT activity and browning by hormonal mediators was the subject of some recent review articles ([@B62]; [@B132]; [@B100]). In this section, we present some of the recent literature reports on BAT regulation, linking those to the overall understanding of BAT physiology and function. [Figure 1](#F1){ref-type="fig"} provides an overall picture of the regulation of brown fat activity and browning by hormones and circulating factors.

![Circulating regulators of BAT and their origin. Hypothalamus plays an important role in regulating brown fat activity through regulating the sympathetic nervous system activity. Several circulating regulators impact BAT functioning and browning. Many of these act through increasing the sympathetic nervous activity to BAT and WAT, increasing UCP1 expression.](fphys-10-00038-g001){#F1}

Hyperinsulinemia, induced by daily injection of insulin, was associated with a reduction in IWAT and IBAT respiratory activity ([@B32]). Leptin, a hormone released by WAT and known for its appetite suppressing effects, was shown to increase SNS activity to BAT ([@B40]). However, the IBAT SNS activity was shown to be not necessary for leptin-induced weight loss ([@B27]). Proopiomelanocortin (POMC) and Agouti-related protein (AgRP) neurons play a role in leptin-mediated increased SNS activity to BAT, while the AgRP are the major regulators of increased SNS activity to the inguinal fat in response to leptin in mice ([@B11]). Significantly reduced levels of the β3-adrenergic receptor, PGC-1α, and UCP1, were found in the leptin-deficient ob/ob (--/--) mice ([@B105]) which were improved by injection of capsules containing poly-[L]{.smallcaps}-lysine-embedded engineered 3T3-L1 adipocytes constitutively expressing leptin ([@B36]).

Increased thyroid hormone activity is known to promote energy expenditure. One study showed that both hypothyroidism, as well as hyperthyroidism, led to increased WAT browning in mice ([@B173]). The study showed that hyperthyroid mice had higher BAT mass and activity than the hypothyroid mice. The thyroid hormone T3 can increase SNS activity to BAT, increasing BAT activity ([@B99]). Treatment with T4 or administration of T3 to VMH was shown to be associated with the browning of WAT ([@B103]). In humans too, the cold-induced increase in energy expenditure was shown to be associated with circulating T3 levels ([@B50]). The action of T3 on BAT activity was shown to be mediated by a reduction of endoplasmic reticulum stress in the VMH ([@B104]). Angiotensin type 2 receptor (AT2R) was shown to play a role in T3-induced upregulation of browning genes in WAT ([@B157]) and an AT2R agonist was shown to increase WAT browning. On the other hand, deleting the AT1aR was shown to be associated with IWAT browning ([@B161]). Injection of angiotensin 1--7 peptide through a micro-osmotic pump was shown to increase in BAT size and UCP1 levels as well as increase thermogenesis in subcutaneous WAT without affecting UCP1 levels there ([@B112]). A thyroid receptor beta (TR-β) specific agonist GC-1 was shown to increase energy expenditure and prevent weight gain in rats ([@B166]). The molecular mechanisms involved in the TH-induced increase in thermogenesis was reviewed in [@B172] and involves both direct activation of thyroid hormone receptors in the adipose tissues as well as indirectly through the activation of hypothalamic neurons. A recent study has identified the carbohydrate response element binding protein (ChREBP) as one of the targets of T3 which regulates the UCP1 expression in brown adipocytes ([@B70]).

Sex hormones play an important role in regulating brown fat function. As several studies have shown that females have higher BAT activity than males, it is likely that estrogen levels impact BAT activity ([@B47]). Reduced levels of estradiol (E2), an ovary-derived hormone, are associated with reduced BAT activity ([@B97]) and E2 treatment can increase BAT activity by activating hypothalamic AMPK ([@B98]). The roles of E2 in regulating thermogenesis were recently reviewed ([@B52]). Pharmacological activation of estrogen receptor β(ER-β) was shown to increase BAT volume and energy expenditure ([@B128]). Progesterone, a hormone associated with gestation, was shown to cause a brown-to-white conversion of BAT in mice ([@B106]). Removal of BAT prior to conception led to maternal and fetal hyperlipidemia and larger fetuses. Inhibiting follicle stimulating hormone (FSH) through a polyclonal antibody was shown to induce beiging, activate BAT and thermogenesis and reduce WAT ([@B95]). BAT was shown to have the highest expression of Follistatin (Fst), previously known as FSH-suppressing protein. Overexpression of Fst was shown to increase BAT mass as well of browning of WAT ([@B145]). These results suggest that FSH has an inhibitory effect on BAT activity and browning. Castration was shown to increase browning of IWAT in mice ([@B59]).

Some other hormones or peptides have been reported to affect BAT functioning. These include ghrelin, which negatively correlated with BAT activity ([@B23]) and erythropoietin (EPO), which was shown to promote thermogenic activity ([@B81]).

Small molecule circulating regulators of BAT physiology include hydrogen sulfide (H~2~S) ([@B147]), pyruvate ([@B148]) and abscisic acid ([@B152]).

Brown fat is also a source of various BATokines which can impact other organs. FGF21 is a well-studied batokine, though it can also be released by liver and WAT. FGF21 can act on BAT and WAT through the central nervous system and increase the SNS activity, leading to weight loss and increased energy expenditure ([@B17]; [@B123]; [@B37]). FGF21 can also act in an autocrine manner on the tissue. FGF21 can also lead to browning of WAT through increased PPAR-γ ([@B38]) and PGC1-α activity ([@B44]). A clinical trial showed a reduction in body weight and improvements in lipid metabolism in obese patients on treatment with LY2405319, analog of FGF-21 ([@B49]). Batokines and their effects have been reviewed in [@B165].

Dietary and Plant-Derived Molecules
===================================

Alterations in diets and major dietary components have been shown to be associated with variation in the activity of BAT. [Figure 2](#F2){ref-type="fig"} depicts some of the food items whose derived compounds have been shown to increase BAT activity and browning of WAT.

![Food-derived molecules shown to be involved in BAT activation and browning, and their sources. Several diet-derived molecules have been shown to activate brown fat and browning. These are obtained from both plant and animal products.](fphys-10-00038-g002){#F2}

Macromolecular Composition of Diets
-----------------------------------

The macromolecular composition of diets can affect BAT activity and browning. A comparison of several diets showed that a high protein diet was associated with higher amounts of BAT ([@B33]). However, other studies have shown that diets low in protein diet were associated with increased BAT activity and browning ([@B126]; [@B78]). Some studies have observed that the source of protein affects diet-induced thermogenesis (DIT) and BAT UCP1 levels ([@B42]; [@B91]). The BAT response on a high fat diet was time-dependent -- shorter (2--4 week) high-fat diet increase UCP1 levels in BAT, while longer feeding with HFD (20 weeks) bringing them back to normal levels ([@B119]).

Surprisingly, sucrose intake was shown to increase BAT activity ([@B101]; [@B164]). Addition of dietary fiber to a high-fat diet (HFD) increased lipolysis and the levels of various thermogenic proteins in WAT ([@B56]).

Dietary Components Known to Increase BAT Activity
-------------------------------------------------

Long-term feeding of specific diets may cause alterations in the BAT composition and activity. Our work has shown that a high fat, low carbohydrate ketogenic (KG) diet ([@B149]) increased BAT volume and the expression of mitochondrial proteins in BAT in mice. A novel dietary additive, which can be given along with a normal carbohydrate-level diet and yet can increase blood ketone levels, was developed in the lab of R.L. Veech. This ketone ester, when given to mice in liquid diets, produced blood ketone (β-hydroxybutyrate) levels much greater than that achieved with the KG diets without the need to restrict carbohydrate intake ([@B150]). The increased ketone levels were associated with several positive metabolic effects. These include a significant activation of BAT and mitochondrial biogenesis in this tissue, increased UCP1 levels in WAT. Dietary administration of medium chain triglycerides (MCTs) ([@B187]) as well as MCT-enriched diacylglycerol oil (MCE-DAG) ([@B77]), which also increase blood ketone levels, was shown to activate BAT. Azelaic acid, a pharmacological activator of Olfr544, was shown to induce ketogenesis in the liver and increased UCP1 expression in the BAT ([@B175]). All these results indicate that increased blood ketone levels can modulate brown fat activity. Other diet-derived small molecule BAT activators have also been identified. These include butyrate ([@B92]), acetate ([@B135]) and succinate ([@B108]). These studies suggest that elevation of TCA cycle metabolites can trigger changes in BAT activity. [Table 1](#T1){ref-type="table"} lists some of the diet-derived small molecules shown to increase BAT activity and browning of WAT.

###### 

Some diet-derived small molecules known to activate brown fat and/or browning.

  --
  --

There is a significant interest in identifying dietary additives that can improve BAT activity. Several dietary BAT modulators have been identified. [Figure 2](#F2){ref-type="fig"} provides a summary of reported dietary molecules that increase BAT activity and browning.

Feeding mice a diet rich in fish oil ([@B7]), olive oil ([@B143]) or PUFAs ([@B28]; [@B124]; [@B51]) or conjugated linoleic acid ([@B140]) was shown to activate BAT and browning in rodents.

Chronic cold exposure was associated with increased bile acid production by the liver and modulation of the bile acid production modulated the thermogenic response ([@B174]). Studies have shown activating effect of bile acids on BAT activity in rodents ([@B171]; [@B39]) and humans ([@B21]).

Supplementation with non-pungent capsinoids (compounds associated with the hotness of peppers) ([@B182]) as well as grains of paradise ([@B153]) was associated with increased thermogenesis. Activation of the transient receptor potential cation channel subfamily V member 1 (TRPV1) by these compounds ([@B10]) leads to increased SNS activity to induce BAT ([@B137]). Selective ablation of inguinal WAT (IWAT) sensory neurons by capsaicin treatment was shown to reduce the norepinephrine turnover not only in the IWAT but also in the IBAT, and reduce UCP1 expression in IBAT ([@B117]). Similarly, loss of TRPV2 was associated with impaired thermogenic response to β-adrenergic stimulation and poor cold tolerance ([@B155], 2). Expression of TRPV2 is significantly increased during brown fat differentiation, and TRPV2-agonists inhibited the brown adipocyte differentiation ([@B156]). Human studies have shown that increased energy expenditure following capsaicin treatment was observed only in individuals with the active BAT ([@B154]). Supplementation of vanillic acid also increases BAT activity ([@B69]). These studies have shown that BAT plays a role in the increased energy expenditure following intake of "hot" foods and have elucidated the underlying mechanisms, providing new targets to modulate BAT activity.

Several studies have shown that intake of tea-derived compounds is associated with increased thermogenic capacity in mice ([@B116]) and humans ([@B118]; [@B184]).

Resveratrol (RSV), a flavonoid found on the skin of grapes, and related compounds have been shown to activate BAT and increase thermogenesis ([@B3]; [@B84]; [@B89]) likely through AMPKα activation ([@B170]). A combination of RSV with Quercetin, active compound from onion peels ([@B5]), and pentamethyl quercetin (PMQ) ([@B57]) was shown to induce BAT activation and browning.

Dietary supplementation of raspberry to mice on a high-fat diet ([@B178]) or oral treatment with raspberry ketone ([@B88]) was recently shown to increase beiging through AMPK activation ([@B189]).

While the list given in this section is not exhaustive, it is clear that BAT and WAT are responsive to diet composition, type of lipid and to several natural compounds. This also calls for an appropriate control diet as well as a careful comparison of the macro and micronutrient composition of diets while designing dietary studies involving BAT activators.

Pharmacological Activators of Brown and Beige Fat
=================================================

Several pharmacological activators of brown fat and browning have been reported. These include β3-adrenergic receptor agonist ([@B31]), PPAR-γ activators ([@B177]; [@B96]; [@B107]), PGC-1α stabilizers ([@B127]), PPAR-α agonist ([@B129]), AMPK activators ([@B75], [@B76]; [@B158]) and PDE5 inhibitors Sildenafil and Tadalafil ([@B102]; [@B90]). Several other pharmacological modulators of BAT activity and browning have been reported. While some of them are expected from our understanding of brown fat biology, the other modulators identified could be used to gain further insights into the mechanisms of regulation of brown fat activation and browning.

Effect of Physical Exercise on BAT and Browning
===============================================

Physical exercise can have beneficial effects on general metabolism and physiology. Several rodent studies showed increased BAT activity and browning of WAT in rodents on exercise ([@B34]; [@B2]; [@B125]). However, a systematic review concluded that regular exercise is not a major stimulus for increased BAT activity even though an increase may be observed in animals consuming high-fat diets or with low endogenous UCP1 levels ([@B45]). Most human studies have shown a negative correlation of BAT activity with exercise ([@B113]; [@B159]). Endurance-trained athletes have reduced BAT activity compared to sedentary controls ([@B159]). Endurance training was also not associated with beiging of abdominal or subcutaneous WAT ([@B160]). Two weeks of exercise training decreased insulin-mediated glucose uptake by BAT in healthy middle-aged men ([@B113]). Thus, human studies have generally shown that metabolic benefits of exercise are not mediated by increased BAT activity and browning.

Several exercise-induced mediators have been suggested to play a role in browning of WAT in rodents. These include myokines such as Irisin, a hormone released by skeletal muscles whose levels increase following exercise ([@B18]), IL-6 ([@B80]) and β-amino isobutyric acid (BAIBA) ([@B131]), etc. While the initial findings of existence of irisin were questioned due to non-specificity of the antibodies ([@B6]; [@B1]), a mass spectrometry-based analysis confirmed the presence of irisin in human plasmas and its increase following exercise ([@B67]). In humans, habitual physical activity was shown to be positively correlated with serum irisin levels ([@B22]) but a lower active BAT ([@B146]). A systematic review of the literature has concluded that it may not be possible to conclude an association between physical activity and Irisin or PGC-1α because of lack of precision of available methods ([@B35]). Thus, further research is needed to evaluate the effects of myokines on brown fat physiology and browning process, taking into consideration that trained individual may show a divergent response than untrained/sedentary individuals ([@B168]).

Conclusion and Future Directions
================================

It is now clear that BAT is a metabolically active tissue and when activated, can clear very high levels of glucose and lipids on a per weight tissue basis. Increased BAT activity is associated with several metabolic benefits such as reduced body weight and improved glucose control. The beiging of WAT holds promise to further increase the metabolic benefits.

An important, less-emphasized factor regulating the activity of this tissue is the ambient temperature. Most of our knowledge has come from studies conducted under cold conditions which lead to chronic BAT activation. Housing at or near thermoneutral temperature is associated with significantly reduced basal metabolic rate and UCP1 levels and higher body fat ([@B141]). Chronic exposure to thermoneutral and warm conditions significantly reduce the levels and activity of this tissue in rodents ([@B29]) and humans ([@B162]). Warmer temperatures are also associated with higher incidences of diabetes and glucose intolerance in humans ([@B13]). As most humans live at or near thermoneutrality, only a small fraction of the total BAT may be active in humans under normal living conditions. Similarly, ambient temperature may also affect the response to "inducers" of BAT activity. For BAT research to be applicable to humans, a careful choice of ambient temperature is needed.

While physical exercises of different modalities are generally associated with improved metabolic parameters, studies generally suggest a divergent response of WAT browning to exercise in rodents vs. humans. Human studies have generally shown a reduced BAT activity and no significant effect on browning, while rodent studies have generally shown browning of WAT by exercising. It is plausible that this divergent response may be related to the different ambient temperatures, along with other factors such as greater genetic and dietary diversity of humans compared to the mice studied. Nonetheless, the tantalizing possibility exists of further improving the benefits of exercise in humans through a parallel activation of browning by environmental, dietary or pharmacological treatments. Various exercise-induced factors have also been identified, with the goal to extend the metabolic benefits of exercising to sedentary individuals.

Given our increased understanding of the metabolic effects of the activated BAT, novel approaches to increase its activity are being explored. Using optical and electrical genetic stimulation of specific neurons in the sympathetic nervous offers an interesting option ([@B46]) to modulate the activity of BAT or to induce browning in specific depots. Oral genetic therapy to manipulate BAT has been reported in mice ([@B63]) and was able to increase BAT mass and activity. Similarly, stem cells derived from rat and human WAT were successfully differentiated into a three dimensional BAT using hydrogels ([@B181]). The effect of gut microbiota on BAT activity and browning is increasingly being recognized ([@B111]) and would likely be a fertile area of research.

Novel small molecule activators of BAT and brite cells are being developed, along with novel delivery systems such as functionalized nanoparticles ([@B180]) and lipid nanocarriers ([@B190]). Such delivery systems hold promise for precise and efficient delivery of bioactives to their target site(s). Similarly, several dietary additives that activate BAT and browning have been reported. However, long-term studies with pharmacological and dietary treatments are needed. Future studies can also investigate the combined dietary and pharmacological treatments. Further research is likely to generate more information on BAT and brite biology and its interaction with various other physiological processes.
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